Literature DB >> 14699464

Severe West Nile virus disease in healthy adults.

Mimi Emig1, Douglas J Apple.   

Abstract

The inpatient records of 44 case patients with West Nile virus infection hospitalized in 2002 were reviewed. Sixty-five percent of the case patients had encephalitis, and 35% had aseptic meningitis. There was no significant difference in the distribution of aseptic meningitis versus encephalitis among adults aged < or =50 years compared with adults aged > or =65 years. Focal weakness, likely due to anterior horn cell involvement, was present in 10 case patients (overall rate, 23%; rate among patients with encephalitis, 34%). Case patients with focal weakness who were aged < or =50 years had monoparesis, whereas those aged > or =65 years had paraparesis or quadriparesis. The overall mortality rate was 14%, and the mortality rate in patients aged > or =65 years was 35%. Increased age was associated with an increased mortality rate. The presence of paraparesis or quadriparesis was not independently predictive of mortality.

Entities:  

Mesh:

Year:  2003        PMID: 14699464     DOI: 10.1086/380458

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

Review 1.  Current trends in West Nile virus vaccine development.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2014-04-01       Impact factor: 5.217

2.  Focal neurological injury caused by West Nile virus infection may occur independent of patient age and premorbid health.

Authors:  Sandeep Bhangoo; Rowena Chua; Chris Hammond; Zebadiah Kimmel; Irene Semenov; Aleksandar Videnovic; John Kessler; Mark Borsody
Journal:  J Neurol Sci       Date:  2005-07-15       Impact factor: 3.181

3.  IPS-1 is essential for the control of West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Daphne Y Ma; Sunil Thomas; Jennifer M Lund; Nu Zhang; Stephane Daffis; Alexander Y Rudensky; Michael J Bevan; Edward A Clark; Murali-Krishna Kaja; Michael S Diamond; Michael Gale
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

Review 4.  West Nile virus: review of the literature.

Authors:  Lyle R Petersen; Aaron C Brault; Roger S Nasci
Journal:  JAMA       Date:  2013-07-17       Impact factor: 56.272

5.  Advances in Infectious Encephalitis: Etiologies, Outcomes, and Potential Links with Anti-NMDAR Encephalitis.

Authors:  Arun Venkatesan
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

6.  Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar.

Authors:  Mehul S Suthar; Margaret M Brassil; Gabriele Blahnik; Michael Gale
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

7.  Protective behavior and West Nile virus risk.

Authors:  Mark Loeb; Susan J Elliott; Brian Gibson; Margaret Fearon; Robert Nosal; Michael Drebot; Colin D'Cuhna; Daniel Harrington; Stephanie Smith; Pauline George; John Eyles
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

8.  West Nile Virus Encephalitis.

Authors:  James L Dean; Brandon J Palermo
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.663

9.  Host genetic risk factors for West Nile virus infection and disease progression.

Authors:  Abigail W Bigham; Kati J Buckingham; Sofia Husain; Mary J Emond; Kathryn M Bofferding; Heidi Gildersleeve; Ann Rutherford; Natalia M Astakhova; Andrey A Perelygin; Michael P Busch; Kristy O Murray; James J Sejvar; Sharone Green; John Kriesel; Margo A Brinton; Michael Bamshad
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

10.  Neuromuscular manifestations of west nile virus infection.

Authors:  A Arturo Leis; Dobrivoje S Stokic
Journal:  Front Neurol       Date:  2012-03-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.